Inspira Technologies Email Format
Medical Equipment ManufacturingCentral District, Israel51-200 Employees
Inspira Technologies, based in Ra'ananna in the Central District of Israel, develops medical devices for respiratory support and real-time blood monitoring. Its ART100 system is cleared by the U.S. FDA for cardiopulmonary bypass and is approved for ECMO procedures outside the United States, serving hospitals and surgical centers as a platform for future expansion. The ART500 is being developed to deliver oxygenation while patients are awake and breathing spontaneously. In addition, Inspira is advancing HYLA, a blood sensor platform that provides continuous, non-invasive monitoring. In April 2026 the company announced a joint development agreement with Qarakal Quantum to develop cryogenic interconnect solutions for superconducting quantum systems.